Vaccine for Lyme disease soon
Pfizer and Moderna are ready to introduce a vaccine for Lyme disease by 2030.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Pfizer and Moderna are ready to introduce a vaccine for Lyme disease by 2030.
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.
Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose,.
Bharat Biotech, an Indian developer of vaccines for infectious diseases, will roll out its nasal Covid-19 vaccine for patients above 18 years in.
India’s drug regulator, the Central Drugs Standard Control Organisation, has given its nod for the restricted use of the world’s first intra-nasal vaccine.
An mRNA vaccine has been found to be effective against all 20 known strains of influenza A and B in animal models
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.
Shortage of cholera vaccines forces global agencies to shift to single doses instead of recommended two